vs
Phathom Pharmaceuticals, Inc.（PHAT）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
Phathom Pharmaceuticals, Inc.的季度营收约是REGIS CORP的1.0倍（$57.6M vs $57.1M），Phathom Pharmaceuticals, Inc.同比增速更快（94.1% vs 22.3%），REGIS CORP自由现金流更多（$891.0K vs $-167.0M）
Phathom Pharmaceuticals是一家临床阶段生物制药公司，专注于研发和商业化胃肠道疾病的创新疗法，其核心候选产品针对酸相关疾病、炎症性肠病等适应症，主要服务北美及欧洲地区的患者群体。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
PHAT vs RGS — 直观对比
营收规模更大
PHAT
是对方的1.0倍
$57.1M
营收增速更快
PHAT
高出71.9%
22.3%
自由现金流更多
RGS
多$167.9M
$-167.0M
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $57.6M | $57.1M |
| 净利润 | — | $456.0K |
| 毛利率 | 86.7% | — |
| 营业利润率 | — | 10.8% |
| 净利率 | — | 0.8% |
| 营收同比 | 94.1% | 22.3% |
| 净利润同比 | 71.6% | -94.0% |
| 每股收益（稀释后） | — | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PHATRGS
| Q4 25 | $57.6M | $57.1M | ||
| Q3 25 | $49.5M | $59.0M | ||
| Q2 25 | $39.5M | $60.4M | ||
| Q1 25 | $28.5M | $57.0M | ||
| Q4 24 | $29.7M | $46.7M | ||
| Q3 24 | $16.4M | $46.1M | ||
| Q2 24 | $7.3M | $49.4M | ||
| Q1 24 | — | $49.2M |
净利润PHATRGS
| Q4 25 | — | $456.0K | ||
| Q3 25 | $-30.0M | $1.4M | ||
| Q2 25 | $-75.8M | $116.5M | ||
| Q1 25 | $-94.3M | $250.0K | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | $-85.6M | $-853.0K | ||
| Q2 24 | $-91.4M | $91.2M | ||
| Q1 24 | — | $-2.3M |
毛利率PHATRGS
| Q4 25 | 86.7% | — | ||
| Q3 25 | 87.5% | — | ||
| Q2 25 | 87.2% | — | ||
| Q1 25 | 86.9% | — | ||
| Q4 24 | 87.1% | — | ||
| Q3 24 | 85.6% | — | ||
| Q2 24 | 81.2% | — | ||
| Q1 24 | — | — |
营业利润率PHATRGS
| Q4 25 | — | 10.8% | ||
| Q3 25 | -30.8% | 10.0% | ||
| Q2 25 | -151.7% | 12.1% | ||
| Q1 25 | -276.5% | 8.8% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | -433.0% | 4.6% | ||
| Q2 24 | -1055.4% | — | ||
| Q1 24 | — | 8.3% |
净利率PHATRGS
| Q4 25 | — | 0.8% | ||
| Q3 25 | -60.5% | 2.3% | ||
| Q2 25 | -191.9% | 192.9% | ||
| Q1 25 | -330.7% | 0.4% | ||
| Q4 24 | — | 16.4% | ||
| Q3 24 | -523.3% | -1.9% | ||
| Q2 24 | -1248.6% | 184.7% | ||
| Q1 24 | — | -4.7% |
每股收益（稀释后）PHATRGS
| Q4 25 | — | $0.16 | ||
| Q3 25 | $-0.41 | $0.49 | ||
| Q2 25 | $-1.05 | $43.67 | ||
| Q1 25 | $-1.31 | $0.08 | ||
| Q4 24 | — | $2.71 | ||
| Q3 24 | $-1.32 | $-0.36 | ||
| Q2 24 | $-1.56 | $38.40 | ||
| Q1 24 | — | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $130.0M | $18.4M |
| 总债务越低越好 | $209.1M | $113.3M |
| 股东权益账面价值 | $-438.2M | $188.7M |
| 总资产 | $259.1M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资PHATRGS
| Q4 25 | $130.0M | $18.4M | ||
| Q3 25 | $135.2M | $16.6M | ||
| Q2 25 | $149.6M | $17.0M | ||
| Q1 25 | $212.3M | $13.3M | ||
| Q4 24 | $297.3M | $10.2M | ||
| Q3 24 | $334.7M | $6.3M | ||
| Q2 24 | $276.2M | $10.1M | ||
| Q1 24 | — | $5.9M |
总债务PHATRGS
| Q4 25 | $209.1M | $113.3M | ||
| Q3 25 | $207.1M | $111.3M | ||
| Q2 25 | $205.1M | $110.8M | ||
| Q1 25 | $203.2M | $112.0M | ||
| Q4 24 | $201.4M | $111.5M | ||
| Q3 24 | $175.7M | $95.2M | ||
| Q2 24 | $174.4M | $99.5M | ||
| Q1 24 | — | $179.7M |
股东权益PHATRGS
| Q4 25 | $-438.2M | $188.7M | ||
| Q3 25 | $-422.5M | $187.6M | ||
| Q2 25 | $-405.8M | $185.6M | ||
| Q1 25 | $-338.4M | $68.6M | ||
| Q4 24 | $-253.6M | $66.7M | ||
| Q3 24 | $-187.1M | $56.4M | ||
| Q2 24 | $-233.8M | $56.8M | ||
| Q1 24 | — | $-35.8M |
总资产PHATRGS
| Q4 25 | $259.1M | $588.3M | ||
| Q3 25 | $240.3M | $592.1M | ||
| Q2 25 | $250.2M | $599.0M | ||
| Q1 25 | $294.2M | $511.2M | ||
| Q4 24 | $378.3M | $530.1M | ||
| Q3 24 | $387.0M | $508.9M | ||
| Q2 24 | $319.4M | $530.5M | ||
| Q1 24 | — | $543.7M |
负债/权益比PHATRGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-166.8M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $-167.0M | $891.0K |
| 自由现金流率自由现金流/营收 | -290.0% | 1.6% |
| 资本支出强度资本支出/营收 | 0.4% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 3.65× |
| 过去12个月自由现金流最近4个季度 | $-328.9M | $14.9M |
8季度趋势，按日历期对齐
经营现金流PHATRGS
| Q4 25 | $-166.8M | $1.7M | ||
| Q3 25 | $-14.1M | $2.3M | ||
| Q2 25 | $-62.7M | $6.8M | ||
| Q1 25 | $-84.9M | $6.2M | ||
| Q4 24 | $-266.8M | $2.1M | ||
| Q3 24 | $-63.6M | $-1.3M | ||
| Q2 24 | $-70.7M | $5.1M | ||
| Q1 24 | — | $-277.0K |
自由现金流PHATRGS
| Q4 25 | $-167.0M | $891.0K | ||
| Q3 25 | $-14.1M | $1.9M | ||
| Q2 25 | $-62.8M | $6.2M | ||
| Q1 25 | $-84.9M | $5.9M | ||
| Q4 24 | $-266.9M | $1.7M | ||
| Q3 24 | $-63.6M | $-1.4M | ||
| Q2 24 | $-70.8M | $5.1M | ||
| Q1 24 | — | $-326.0K |
自由现金流率PHATRGS
| Q4 25 | -290.0% | 1.6% | ||
| Q3 25 | -28.6% | 3.2% | ||
| Q2 25 | -159.0% | 10.3% | ||
| Q1 25 | -297.9% | 10.3% | ||
| Q4 24 | -899.8% | 3.6% | ||
| Q3 24 | -389.0% | -3.0% | ||
| Q2 24 | -966.2% | 10.3% | ||
| Q1 24 | — | -0.7% |
资本支出强度PHATRGS
| Q4 25 | 0.4% | 1.4% | ||
| Q3 25 | 0.1% | 0.7% | ||
| Q2 25 | 0.2% | 0.9% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.5% | 0.9% | ||
| Q3 24 | 0.3% | 0.0% | ||
| Q2 24 | 0.6% | 0.0% | ||
| Q1 24 | — | 0.1% |
现金转化率PHATRGS
| Q4 25 | — | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PHAT
暂无分部数据
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
